Current Assets
Other Inventory, Net
Regeneron Pharmaceuticals Other Inventory, Net increased by 8.3% to $787.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.8%, from $773.90M to $787.90M. Over 5 years (FY 2020 to FY 2025), Other Inventory, Net shows an upward trend with a 11.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2017
Last reportedQ1 2026Apr 29, 2026
How to read this metric
Significant fluctuations may indicate changes in supply chain strategy, inventory management efficiency, or the accumulation of obsolete materials.
Detailed definition
This category captures miscellaneous inventory items that do not fit into primary classifications like raw materials or...
Peer comparison
Common in manufacturing; peers often group these as 'supplies' or 'other' to simplify balance sheet presentation.
Metric ID:
other_inventory_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $535.00M | $503.70M | $510.00M | $566.50M | $623.90M | $592.80M | $720.70M | $752.30M | $747.90M | $726.20M | $522.10M | $611.50M | $720.70M | $766.70M | $725.70M | $773.90M | $764.40M | $808.80M | $727.50M | $787.90M |
| QoQ Change | — | -5.9% | +1.3% | +11.1% | +10.1% | -5.0% | +21.6% | +4.4% | -0.6% | -2.9% | -28.1% | +17.1% | +17.9% | +6.4% | -5.3% | +6.6% | -1.2% | +5.8% | -10.1% | +8.3% |
| YoY Change | — | — | — | — | +16.6% | +17.7% | +41.3% | +32.8% | +19.9% | +22.5% | -27.6% | -18.7% | -3.6% | +5.6% | +39.0% | +26.6% | +6.1% | +5.5% | +0.2% | +1.8% |
Range$503.70M – $808.80M
CAGR+8.5%
Avg YoY Growth+11.6%
Median YoY Growth+11.3%
Other Inventory, Net at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's other inventory, net?
- Regeneron Pharmaceuticals (REGN) reported other inventory, net of $787.90M in Q1 2026.
- How has Regeneron Pharmaceuticals's other inventory, net changed year-over-year?
- Regeneron Pharmaceuticals's other inventory, net increased by 1.8% year-over-year, from $773.90M to $787.90M.
- What is the long-term trend for Regeneron Pharmaceuticals's other inventory, net?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's other inventory, net has grown at a 11.0% compound annual growth rate (CAGR), from $430.90M to $727.50M.
- What does other inventory, net mean?
- Miscellaneous inventory items held by the company, excluding primary product categories.